(EMAILWIRE.COM, February 25, 2019 ) This PharmSource Trend Report will explore whether the bio/pharma industry is adequately prepared for future cell therapy developments and whether pharma companies and contract manufacturing organizations (CDMOs) are making appropriate investments in the capacity and technology to support the coming opportunity.
This 35-page report gives important, expert insight you won’t find in any other source. 16 tables and figures throughout the report illustrate major points and trends.
Top Market Players:
Cellectis, China
PLA General Hospital, GSK, 3P Biopharmaceuticals, Abzena, Anemocyte SRL, apceth Biopharma GmbH, Areta International, Army Military Medical University (formerly Third Military Medical University), Astellas, Atvio Biotech , Austrianova Singapore, Autolus, Bio Elpida, Bioinova sro, Brammer Bio, CCRM, Celgene, Cell and Gene Therapy Catapult, CellforCure, Cellin Technologies
Get a Sample Report: http://www.reportsweb.com/inquiry&RW00012173025/sample
Scope
This report seeks to achieve the following objectives-
-To describe and evaluate the cell therapy market opportunity;
-To describe and address the adequacy of the network of CDMOs that manufacture for the cell therapy market, both clinical and commercial;
-To assess the outlook for buyers and sellers of contract manufacturing services for cell therapies, including the supply/demand balance.
Table of Contents
1 Executive Summary
2. Introduction
3. Commercial Cell Therapy Experience
4. Cell Therapy Pipeline
5. Next-Generation Technologies
6. Approvals Outlook
7. Cell Therapy Supply Chain
8. Demand Models
9. What It Means
10. Notes on Methodology
11. Appendix
Have any Questions? Ask here @ http://www.reportsweb.com/inquiry&RW00012173025/buying
List of Tables
Table 1 : FDA-Approved, Marketed Cell Therapies
Table 2: Cell Therapy Approvals
Table 3: Cell Therapy CDMOs’ Biological Services
Table 5: Cell Therapy CDMOs’ Packaging Capabilities
Table 6: Cell Therapy CDMO Sites and Associated Cell Source and Types
Table 7: Method of Transfection Used at Cell Therapy CDMO Sites
Table 8: Model for Cell Therapy Clinical Requirements
Table 9: Model for Cell Therapy Commercial Requirements
Table 10: Model for Yearly Cell Therapy Commercial Requirements
List of Figures
Figure 1: Kymriah Global Sales Forecast 2018-2024 ($B)
Figure 2: Yescarta Global Sales Forecast 2018-2024 ($B)
Figure 3: Pipeline Cell Therapy Candidates
Figure 4: Phase I Trial Starts by Sponsor Type
Figure 5: Phase II Planned Trial Starts by Sponsor Type
Figure 6: Phase III Planned Trial Starts by Sponsor Type
Get Complete Report @ http://www.reportsweb.com/buy&RW00012173025/buy/4995
Key features of the Worldwide Cell Therapy Market Research Report:
This report is required reading for-
-CMO executives who must have deep understanding of the Cell Therapy marketplace to make strategic planning and investment decisions.
-Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
-Pharmaceutical and Biotech companies involved in the development of Cell Therapies or Cell Therapy technologies.
-Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
